UPMC Hillman Cancer Center

CCSG Acknowledgement

Required CCSG Acknowledgement

The NCI requires that publications acknowledge the Hillman CCSG support, and they are tracking compliance. If a Hillman CCSG-supported Shared Resource provided data used in your publication, please include the following statement in the acknowledgment section of your publication(s):

"This project used the Hillman [insert name(s) of shared resource(s)] that [is/are] supported in part by award P30CA047904."

Shared Resource Directors: Please make sure to include this statement on all of your order forms, contracts, etc. as a reminder to your users to acknowledge the Hillman CCSG support.


Overview

The genomic and transcriptomic platforms provided by the Cancer Genomics Facility (CGF) enable a large number of diverse basic, translational, and clinical projects that fall predominantly into three research categories:

  1. Cancer center projects seeking to identify diagnostic biomarkers for cancer risk prediction, early detection, prognosis, and prediction of disease progression.
  2. Projects attempting to elaborate the underlying mechanisms of tumorigenesis in order to improve molecular classification, categorize risk of metastasis and recurrence, and optimize therapeutic approaches.
  3. Studies to delineate previously unknown targets for prospective pharmacological reagents that may lead to novel therapeutic targeting strategies.

The capabilities of the CGF have been tailored to meet the needs of these studies. Learn more about our services and equipment.